FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2949831066> ?p ?o ?g. }

• W2949831066 endingPage "3766" @default.
• W2949831066 startingPage "3757" @default.
• W2949831066 abstract "Background: Preoperative serum tumor markers have been widely used to predict prognosis in stage II and III colorectal cancer (CRC). However, few previous studies addressed the effect of increased preoperative numbers of tumor markers. Methods: Patients with stage II and III CRC who underwent curative resection were included from January 2009 to October 2015. The relationship between serum tumor markers and clinicopathological parameters was analyzed. DFS and OS were compared in stage II and III CRC. Results: The median follow-up was 45 months. In this study, 735 enrolled patients were assessed based on the numbers of increased tumor markers. We found that these increased tumor markers were closely associated with clinical stage, T stage, N stage, tumor location, pathology type, differentiation, lymphatic invasion and vascular invasion (all p values < 0.05). Furthermore, the number of increased tumor markers directly affected the survival of patients with CRC after curative surgery. The 3-year DFS and OS of patients with a score of 0 were 84.0% and 91.0%, respectively, which are much higher than those of patients with a score of 4 (42.9% and 37.8%, respectively) (p < 0.05). The 5-year DFS and OS of patients with a score of 0 were 75.9% and 77.9%, respectively, which are much higher than those of patients with a score of 4 (31.7% and 23.6%, respectively). Interestingly, our results suggested that stage III CRC patients with a score of 0 had longer DFS and OS times than stage II patients with scores of 3 and 4. Further analysis revealed statistically significant differences in OS (p < 0.05) but not in DFS. Conclusions: The number of increased tumor markers could significantly predict prognosis in stage II and III CRC. In addition, these increased tumor markers had direct impacts on metastasis as well as the recurrence status and survival time of stage II and III CRC patients." @default.
• W2949831066 created "2019-06-27" @default.
• W2949831066 creator A5020004419 @default.
• W2949831066 creator A5029508998 @default.
• W2949831066 creator A5033203853 @default.
• W2949831066 creator A5040135272 @default.
• W2949831066 creator A5054785361 @default.
• W2949831066 creator A5060003407 @default.
• W2949831066 creator A5060185042 @default.
• W2949831066 creator A5067139323 @default.
• W2949831066 creator A5067282734 @default.
• W2949831066 creator A5071494012 @default.
• W2949831066 creator A5082805130 @default.
• W2949831066 creator A5090239264 @default.
• W2949831066 date "2019-01-01" @default.
• W2949831066 modified "2023-09-26" @default.
• W2949831066 title "The difference in prognosis of stage II and III colorectal cancer based on preoperative serum tumor markers" @default.
• W2949831066 cites W1941095848 @default.
• W2949831066 cites W1971198000 @default.
• W2949831066 cites W2004126015 @default.
• W2949831066 cites W2009308206 @default.
• W2949831066 cites W2048505008 @default.
• W2949831066 cites W2051240173 @default.
• W2949831066 cites W2056135358 @default.
• W2949831066 cites W2099998407 @default.
• W2949831066 cites W2101235585 @default.
• W2949831066 cites W2102205534 @default.
• W2949831066 cites W2122377763 @default.
• W2949831066 cites W2170365753 @default.
• W2949831066 cites W2272984102 @default.
• W2949831066 cites W2281994516 @default.
• W2949831066 cites W2399203863 @default.
• W2949831066 cites W2468473566 @default.
• W2949831066 cites W2470575266 @default.
• W2949831066 cites W2507511969 @default.
• W2949831066 cites W252266348 @default.
• W2949831066 cites W2594373254 @default.
• W2949831066 cites W2778787212 @default.
• W2949831066 cites W2781525129 @default.
• W2949831066 cites W2783813829 @default.
• W2949831066 cites W2793699917 @default.
• W2949831066 cites W2796242903 @default.
• W2949831066 cites W2807578475 @default.
• W2949831066 cites W2885392309 @default.
• W2949831066 cites W2887029183 @default.
• W2949831066 doi "https://doi.org/10.7150/jca.31660" @default.
• W2949831066 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6636282" @default.
• W2949831066 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31333793" @default.
• W2949831066 hasPublicationYear "2019" @default.
• W2949831066 type Work @default.
• W2949831066 sameAs 2949831066 @default.
• W2949831066 citedByCount "17" @default.
• W2949831066 countsByYear W29498310662020 @default.
• W2949831066 countsByYear W29498310662021 @default.
• W2949831066 countsByYear W29498310662022 @default.
• W2949831066 countsByYear W29498310662023 @default.
• W2949831066 crossrefType "journal-article" @default.
• W2949831066 hasAuthorship W2949831066A5020004419 @default.
• W2949831066 hasAuthorship W2949831066A5029508998 @default.
• W2949831066 hasAuthorship W2949831066A5033203853 @default.
• W2949831066 hasAuthorship W2949831066A5040135272 @default.
• W2949831066 hasAuthorship W2949831066A5054785361 @default.
• W2949831066 hasAuthorship W2949831066A5060003407 @default.
• W2949831066 hasAuthorship W2949831066A5060185042 @default.
• W2949831066 hasAuthorship W2949831066A5067139323 @default.
• W2949831066 hasAuthorship W2949831066A5067282734 @default.
• W2949831066 hasAuthorship W2949831066A5071494012 @default.
• W2949831066 hasAuthorship W2949831066A5082805130 @default.
• W2949831066 hasAuthorship W2949831066A5090239264 @default.
• W2949831066 hasBestOaLocation W29498310661 @default.
• W2949831066 hasConcept C121608353 @default.
• W2949831066 hasConcept C126322002 @default.
• W2949831066 hasConcept C143998085 @default.
• W2949831066 hasConcept C146357865 @default.
• W2949831066 hasConcept C151730666 @default.
• W2949831066 hasConcept C2778740770 @default.
• W2949831066 hasConcept C2779013556 @default.
• W2949831066 hasConcept C2780091936 @default.
• W2949831066 hasConcept C3017532760 @default.
• W2949831066 hasConcept C526805850 @default.
• W2949831066 hasConcept C71924100 @default.
• W2949831066 hasConcept C86803240 @default.
• W2949831066 hasConcept C90924648 @default.
• W2949831066 hasConceptScore W2949831066C121608353 @default.
• W2949831066 hasConceptScore W2949831066C126322002 @default.
• W2949831066 hasConceptScore W2949831066C143998085 @default.
• W2949831066 hasConceptScore W2949831066C146357865 @default.
• W2949831066 hasConceptScore W2949831066C151730666 @default.
• W2949831066 hasConceptScore W2949831066C2778740770 @default.
• W2949831066 hasConceptScore W2949831066C2779013556 @default.
• W2949831066 hasConceptScore W2949831066C2780091936 @default.
• W2949831066 hasConceptScore W2949831066C3017532760 @default.
• W2949831066 hasConceptScore W2949831066C526805850 @default.
• W2949831066 hasConceptScore W2949831066C71924100 @default.
• W2949831066 hasConceptScore W2949831066C86803240 @default.
• W2949831066 hasConceptScore W2949831066C90924648 @default.
• W2949831066 hasIssue "16" @default.
• W2949831066 hasLocation W29498310661 @default.

• next